Back
Day Range
$6.60
$7.02
52-Week Range
$2.30
$8.60
Volume
236,196
50D / 200D Avg
$7.20
/
$4.62
Prev Close
$6.90
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (633 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -14.2 | 0.2 |
| P/B | 7.8 | 2.8 |
| ROE % | -61.0 | 3.7 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.2 | 0.2 |
Analyst Price Target
Hold
$12.00
+74.9%
Forward EPS
-$0.50
Est. Revenue
1.27M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$1.16
$0.61 – $1.98
|
260.97M | 1 |
| FY2029 |
-$0.02
-$0.03 – -$0.01
|
90.99M | 1 |
| FY2028 |
$0.07
$0.04 – $0.13
|
71.96M | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-09 | -$0.12 | -$0.14 | -15.7% |
| 2025-11-20 | -$0.12 | -$0.14 | -16.7% |
| 2025-08-11 | -$0.12 | -$0.13 | -8.3% |
| 2025-05-19 | -$0.14 | -$0.12 | +14.3% |
| 2025-03-12 | -$0.13 | -$0.13 | 0.0% |
| 2024-08-14 | -$0.13 | -$0.11 | +15.4% |
| 2024-05-20 | -$0.13 | -$0.11 | +15.4% |
| 2024-03-07 | -$0.13 | -$0.11 | +15.4% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Debt/Equity of 0.18 — conservative balance sheet
Negative free cash flow of -32.76M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-61.00%
ROIC-34.92%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.18
Current Ratio7.45
Interest Coverage-100.93
Valuation
P/E Ratio
-14.16
Forward P/EN/A
P/B Ratio7.83
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -42.63M |
| ROE | -61.00% | ROA | -40.00% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -32.76M |
| ROIC | -34.92% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.18 | Current Ratio | 7.45 |
| Interest Coverage | -100.93 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -14.16 | Forward P/E | N/A |
| P/B Ratio | 7.83 | P/S Ratio | N/A |
| PEG Ratio | -0.53 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 474.46 | Fwd Earnings Yield | N/A |
| FCF Yield | -5.43% | ||
| Market Cap | 603.75M | Enterprise Value | 601.49M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -42.63M | -31.75M | -29.16M | -33.76M | -27.27M |
| EPS (Diluted) | -0.53 | -0.45 | -0.42 | -0.53 | -0.67 |
| Gross Profit | -1.23M | -1.10M | -1.07M | -979,000.0 | -776,000.0 |
| Operating Income | -42.29M | -36.04M | 35.68M | -32.14M | -13.79M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 106.58M | 86.20M | 107.39M | 120.15M | 42.22M |
| Total Liabilities | 29.48M | 23.54M | 22.91M | 14.49M | 76.99M |
| Shareholders' Equity | 77.10M | 62.67M | 84.48M | 105.66M | -34.78M |
| Total Debt | 13.73M | 12.54M | 13.28M | 5.19M | 53.96M |
| Cash & Equivalents | 15.98M | 13.72M | 12.66M | 5.84M | 23.24M |
| Current Assets | 78.30M | 64.23M | 85.76M | 106.48M | 32.64M |
| Current Liabilities | 10.51M | 8.68M | 7.10M | 4.34M | 4.41M |